Diego Centonze

University of Rome Tor Vergata — Italy

Medicine · Health Sciences

97h-index32.4kcitations662works3.92yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Multiple Sclerosis Research Studies(266), Neuroscience and Neuropharmacology Research(173), Neuroinflammation and Neurodegeneration Mechanisms(72), Cannabis and Cannabinoid Research(60), Polyomavirus and related diseases(49)

Publications661 total

Short-interval intracortical inhibition is related to high-frequency cortico-cortical functional connectivity in the human brain
Cerebral Cortex·2026
Sleep Macrostructure, Cyclic Alternating Pattern and <scp>CSF</scp> Cytokines in De Novo Relapsing–Remitting Multiple Sclerosis: A Controlled Polysomnographic Study
Journal of Sleep Research·2025Open Access
Noradrenergic control of bone marrow and thymus by AgRP neurons is impaired in experimental multiple sclerosis
Cell Reports·2025Open Access
Individualized psychotherapy reveals a very high prevalence of adverse life events in functional neurological disorders
Frontiers in Psychiatry·2025Open Access
IL-1β contributes to neurological disability in NMOSD AQP4 + Patients
Neurological Sciences·2025Open Access
Placebo Responses in Trials for Multiple Sclerosis
Neurologic Clinics·2025
Neurogenic Dysphagia: Peripheral and Central Neuromodulation
Clinics and Practice·2025· 1 citedOpen Access
The effects of daylight saving time and clock time transitions on sleep and sleepiness: a systematic review
Sleep Medicine Reviews·2025
Pharmacodynamics and Pharmacokinetics of Ublituximab Compared with Other Anti-Cd20 Monoclonal Antibodies for Multiple Sclerosis Treatment
Current Neuropharmacology·2025· 2 citedOpen Access
Structural and Functional Assessment of the Macular Inner Retinal Layers in Multiple Sclerosis Eyes Without History of Optic Neuropathy
Journal of Clinical Medicine·2025Open Access
The use of high-efficacy disease-modifying therapies in multiple sclerosis: recommendations from an expert Delphi consensus
Journal of Neurology·2025· 1 citedOpen Access
Switch from fingolimod to ozanimod for safety or intolerance reasons
Therapeutic Advances in Neurological Disorders·2025Open Access
Subcutaneous Ocrelizumab in Patients With Multiple Sclerosis
Neurology·2025
Investigating depression in multiple sclerosis: an Italian Delphi consensus on clinical manifestations, diagnosis and treatment
Frontiers in Psychiatry·2025Open Access
New variants and genotype–phenotype correlation in <i>KIF5A</i> mutation: the contribution of a large Italian cohort
Journal of Medical Genetics·2025Open Access
Cladribine tablets in the new multiple sclerosis era
Therapeutic Advances in Neurological Disorders·2025· 3 citedOpen Access
Sphingosine‐1‐Phosphate Receptor Modulators for the Treatment of Ulcerative Colitis: A Narrative Review Focusing on Safety
United European Gastroenterology Journal·2025· 3 citedOpen Access
Potential use of the SARS-CoV-2 monoclonal antibody sipavibart in people with multiple sclerosis: definition of different patient archetypes from an Italian expert group perspective
Journal of Neurology·2025· 1 cited
Diagnostic uncertainty in the era of biosimilar natalizumab—The case for harmonizing anti-JCV antibody testing
Multiple Sclerosis Journal·2025· 2 cited
MicroRNA-142-3p shuttling in extracellular vesicles marks regulatory T cell dysfunction in multiple sclerosis
Science Translational Medicine·2025· 4 cited
page 1 of 34Next →

Frequent Co-authors

Giorgio Bernardi(35), Paolo Calabresi(24), Paolo Gubellini(15), Antonio Pisani(11), Silvia Rossi(11), Alessandra Musella(11), Barbara Picconi(8), Luca Battistini(6), Valentina De Chiara(6), Georgia Mandolesi(6), Antonietta Gentile(6), Roberto Furlan(5), Gianvito Martino(5), Mauro Maccarrone(5), Diego Fresegna(5), Chiara Prosperetti(5), Paul Greengard(4), Francesca De Vito(4), Silvia Bullitta(4), Girolama Alessandra Marfia(4)